VPS52 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 8.48839887268582E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.01960000442602E-08 |
Normal-vs-Stage2 |
1.01699999532912E-08 |
Normal-vs-Stage3 |
5.64825963778048E-12 |
Normal-vs-Stage4 |
6.09700068210373E-11 |
Stage1-vs-Stage2 |
9.334200E-02 |
Stage1-vs-Stage3 |
3.118200E-03 |
Stage1-vs-Stage4 |
3.042300E-02 |
Stage2-vs-Stage3 |
6.418000E-01 |
Stage2-vs-Stage4 |
8.813000E-01 |
Stage3-vs-Stage4 |
7.358400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
6.75399736138615E-11 |
Normal-vs-AfricanAmerican |
5.43710000022735E-07 |
Normal-vs-Asian |
3.191800E-02 |
Caucasian-vs-AfricanAmerican |
5.518200E-01 |
Caucasian-vs-Asian |
6.777600E-01 |
AfricanAmerican-vs-Asian |
8.650600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
4.08073574931223E-12 |
Normal-vs-Female |
8.47450000174277E-08 |
Male-vs-Female |
1.158890E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.89577999999413E-05 |
Normal-vs-Age(41-60Yrs) |
1.41849998414045E-09 |
Normal-vs-Age(61-80Yrs) |
5.71299674234638E-11 |
Normal-vs-Age(81-100Yrs) |
2.22129999999376E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.705400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.117600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.958200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.277200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.253600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.682800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
3.868300E-02 |
Normal-vs-Grade 2 |
2.13080000310839E-08 |
Normal-vs-Grade 3 |
3.34580141370111E-11 |
Normal-vs-Grade 4 |
1.66533453693773E-14 |
Grade 1-vs-Grade 2 |
6.413900E-04 |
Grade 1-vs-Grade 3 |
1.60945999999607E-05 |
Grade 1-vs-Grade 4 |
1.80529999838086E-08 |
Grade 2-vs-Grade 3 |
1.848480E-02 |
Grade 2-vs-Grade 4 |
1.83072999999645E-05 |
Grade 3-vs-Grade 4 |
7.302900E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
7.58049999993737E-07 |
Normal-vs-ccB subtype |
1.62458935193399E-12 |
ccA subtype-vs-ccB subtype |
3.57170004683383E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.28099997276365E-09 |
Normal-vs-N1 |
2.603100E-04 |
N0-vs-N1 |
4.305400E-01 |
|
|